Raymond James & Associates’s Medidata Solutions, Inc. MDSO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-4,589
| Closed | -$420K | – | 3817 |
|
|
2019
Q3 | $420K | Sell |
4,589
-4,568
| -50% | -$417K | ﹤0.01% | 2776 |
|
|
2019
Q2 | $829K | Sell |
9,157
-43,058
| -82% | -$3.78M | ﹤0.01% | 2335 |
|
|
2019
Q1 | $3.82M | Buy |
52,215
+18,198
| +53% | +$1.31M | 0.01% | 1347 |
|
|
2018
Q4 | $2.29M | Sell |
34,017
-2,055
| -6% | -$145K | ﹤0.01% | 1563 |
|
|
2018
Q3 | $2.64M | Sell |
36,072
-731
| -2% | -$58.5K | ﹤0.01% | 1641 |
|
|
2018
Q2 | $2.96M | Buy |
36,803
+261
| +0.7% | +$19.6K | 0.01% | 1512 |
|
|
2018
Q1 | $2.29M | Buy |
36,542
+1,057
| +3% | +$70.3K | ﹤0.01% | 1619 |
|
|
2017
Q4 | $2.25M | Buy |
35,485
+11,132
| +46% | +$793K | ﹤0.01% | 1622 |
|
|
2017
Q3 | $1.9M | Buy |
24,353
+9,834
| +68% | +$749K | ﹤0.01% | 1680 |
|
|
2017
Q2 | $1.14M | Sell |
14,519
-16,350
| -53% | -$1.14M | ﹤0.01% | 1950 |
|
|
2017
Q1 | $1.78M | Buy |
30,869
+14,157
| +85% | +$765K | ﹤0.01% | 1595 |
|
|
2016
Q4 | $830K | Buy |
+16,712
| New | +$867K | ﹤0.01% | 2035 |
|
|
2015
Q1 | – | Sell |
-14,828
| Closed | -$708K | – | 2430 |
|
|
2014
Q4 | $708K | Buy |
+14,828
| New | +$642K | ﹤0.01% | 1766 |
|
|
2014
Q3 | – | Sell |
-12,800
| Closed | -$548K | – | 2262 |
|
|
2014
Q2 | $548K | Buy |
+12,800
| New | +$531K | ﹤0.01% | 1796 |
|
Other funds holding MDSO
Raymond James & Associates's MDSO Position: Q4 2019 in Review
Raymond James & Associates sold out of Medidata Solutions, Inc. (MDSO) in Q4 2019, closing a stake of 4,589 shares — an estimated $420K sold.
Raymond James & Associates first reported a position in MDSO in Q2 2014 and held it in 14 quarters. The position peaked at $3.82M in Q1 2019. 1 fund tracked by Wall St. Rank holds MDSO as of Q4 2019.
- Raymond James & Associates reported no remaining Medidata Solutions, Inc. position as of Q4 2019 after selling out during the quarter.
- Raymond James & Associates sold 4,589 Medidata Solutions, Inc. shares in Q4 2019, an estimated $420K.
- Raymond James & Associates first reported a position in Medidata Solutions, Inc. in Q2 2014 and held it in 14 quarters.
- Raymond James & Associates's Medidata Solutions, Inc. position peaked at $3.82M in Q1 2019.
- 1 fund tracked by Wall St. Rank held Medidata Solutions, Inc. as of Q4 2019.
Based on Raymond James & Associates's 13F filing for Q4 2019, filed 12 Feb 2020.